ASA: Older stroke survivors have higher risk of cancer

Share this content:
ASA: Cancer Risk Higher for Older Stroke Survivors
ASA: Cancer Risk Higher for Older Stroke Survivors

(HealthDay News) -- Older adults who survive a stroke may have a higher-than-average risk of developing cancer in the next few years, according to a study scheduled to be presented Thursday at the American Stroke Association's International Stroke Conference, held from Feb. 11 to 13 in Nashville, Tenn.

"We already knew that cancer patients are at increased risk of stroke. But what happens when you turn it around and look at cancer risks for ischemic stroke survivors? That was our question," Malik Adil, M.D., lead author from the research team at the Zeenat Qureshi Stroke Institute in St. Cloud, Minn., said in an association news release.

The research team analyzed data from the Vitamin Intervention for Stroke Prevention multicenter trial from 1997 to 2001. They calculated cancer rate differences between the stroke and non-stroke groups at one month, six months, one year, and two years, as well as the risk of death and other cardiovascular events. The findings were compared between stroke survivors who did and didn't develop cancer.

Over two years of follow-up, 2 percent of ischemic stroke survivors were newly diagnosed with a wide range of cancers, including skin, prostate, breast, lung, and bladder cancer. Stroke survivors over age 50 were 1.4 times more likely to develop cancer within two years than their counterparts who were age 50 and under.

Press Release
More Information

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs